Pre-clinical Trials

Clinics, doctors and those diagnosed with any of these illnesses, and who have done their own research on GcMAF, are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is effective for various illnesses, which will help to make it available to the public. Participants are free to stop at any time.

Research universities are supplied, together with 350 clinics and doctors, with 8,000 participants, with GcMAF tested for activity, which can only be done reliably with live cell assays like the one on the front page, which is a time lapse video of the 8th assay done in the laboratory – where you can see GcMAF activating macrophages and eating cancers cells. We are the only people in the world with this technology.

Click “Quality: Video:” cancer cells turned back into healthy cells”  to see what happens to cancer cells when GcMAF is added without macrophages. This again is a world first, and again it has been done in our laboratory.

Our first research abstract paper on our results was published simultaneously on 1st February at the 5th Immunotherapeutics Conference in San Diego California, and at the PMTC Conference at the Universtiy of Sharjah, UAE.

We promised six more scientific research papers during 2013; the first of those, about the histology of GcMAF destroying breast and brain cancer cells, was accepted at the Immunotherapy and Immunomonitoring Conference Krakow, Poland, 22-24th April. But in fact we had written 12 in the first six months of 2013;  All 12 have been peer reviewed and accepted for publication in Immunology conferences or prestigious scientific journals. 16 research papers were published in 2013, and 15 in 2014.

 

Source: https://www.gcmaf.eu/how-gcmaf-works/